CollPlant Biotechnologies
CLGN
6 hedge funds and large institutions have $6.28M invested in CollPlant Biotechnologies in 2020 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
151% more capital invested
Capital invested by funds: $2.5M → $6.28M (+$3.78M)
50% more funds holding
Funds holding: 4 → 6 (+2)
4.7% more ownership
Funds ownership: 5.02% → 9.72% (+4.7%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MIH
Meitav Investment House
Bene-Beraq,
Israel
|
+$3.21M |
| 2 |
SDJVC
St. Denis J. Villere & Co
New Orleans,
Louisiana
|
+$183K |
| 3 |
IMOV
Investment Management of Virginia
Richmond,
Virginia
|
+$175K |
| 4 |
Renaissance Technologies
New York
|
+$131K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$7.16K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
-$32K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
MIH
1
Meitav Investment House
Bene-Beraq,
Israel
| $4.21M | +$3.21M | +312,231 | +285% |
|
|
IMOV
2
Investment Management of Virginia
Richmond,
Virginia
| $1.75M | +$175K | +17,000 | +11% |
|
|
SDJVC
3
St. Denis J. Villere & Co
New Orleans,
Louisiana
| $177K | +$183K | +17,800 | New |
|
|
4
Renaissance Technologies
New York
| $127K | +$131K | +12,697 | New |
|
5
Royal Bank of Canada
Toronto,
Ontario, Canada
| $8K | – | – | – |
|
|
6
UBS Group
Zurich,
Switzerland
| $7K | +$7.16K | +695 | New |
|
|
7
Acadian Asset Management
Boston,
Massachusetts
| – | -$32K | -3,446 | Closed |
|
CLGN Hedge Fund Activity: Q2 2020 in Review
6 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in CollPlant Biotechnologies (CLGN) for Q2 2020, worth a combined $6.28M — up 151% from $2.5M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new CLGN positions and 1 closed out — a net gain of 2 holders — while 2 added to existing stakes and 0 trimmed.
The largest buyer was Meitav Investment House, adding an estimated $3.21M. The largest seller was Acadian Asset Management, exiting entirely with an estimated $32K sold.
- 6 institutional investors held CollPlant Biotechnologies (CLGN) as of Q2 2020, up from 4 in Q1 2020.
- Funds reported $6.28M of CollPlant Biotechnologies stock for Q2 2020, up 151% quarter-over-quarter.
- 3 funds opened new CollPlant Biotechnologies positions in Q2 2020 and 1 closed out, a net change of +2 holders.
- The largest CollPlant Biotechnologies buyer in Q2 2020 was Meitav Investment House, an estimated $3.21M added.
- The largest CollPlant Biotechnologies seller in Q2 2020 was Acadian Asset Management, an estimated $32K sold.
Based on aggregated 13F filings for Q2 2020.